Viewing StudyNCT03603184



Ignite Creation Date: 2024-05-06 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03603184
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-13
First Post: 2018-05-21

Brief Title: Atezolizumab Trial in Endometrial Cancer - AtTEnd
Sponsor: Mario Negri Institute for Pharmacological Research
Organization: Mario Negri Institute for Pharmacological Research

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-10-02
Start Date Type: ACTUAL
Primary Completion Date: 2025-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-05
Completion Date Type: ESTIMATED
First Submit Date: 2018-05-21
First Submit QC Date: July 26 2018
Study First Post Date: 2018-07-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-11
Last Update Post Date: 2024-03-13
Last Update Post Date Type: ACTUAL